Albireo Pharma Inc (ALBO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Sales | 2,428 | 1,966 | 2,716 | 2,131 | 1,912 |
| Gross Profit | 2,428 | 1,966 | 2,716 | 2,131 | 1,912 |
| Operating Expenses | 35,460 | 41,744 | 24,118 | 29,235 | 20,127 |
| Operating Income | -33,032 | -39,778 | -21,402 | -27,104 | -18,215 |
| Interest Expense | 3,389 | 3,955 | 3,397 | 3,639 | 2,388 |
| Pre-tax Income | -36,421 | -43,733 | -24,799 | -30,743 | -20,603 |
| Net Income Continuous | -36,421 | -43,733 | -24,799 | -30,743 | -20,603 |
| Net Income | $-36,421 | $-43,733 | $-24,799 | $-30,743 | $-20,603 |
| EPS Basic Total Ops | -1.90 | -2.29 | -1.16 | -1.96 | -1.38 |
| EPS Basic Continuous Ops | -1.90 | -2.29 | -1.17 | -1.96 | -1.38 |
| EPS Diluted Total Ops | -1.90 | -2.29 | -1.16 | -1.96 | -1.38 |
| EPS Diluted Continuous Ops | -1.90 | -2.29 | -1.17 | -1.96 | -1.38 |
| EPS Diluted Before Non-Recurring Items | -1.90 | -2.29 | N/A | N/A | N/A |
| EBITDA(a) | $-29,726 | $-36,526 | $-18,108 | $-23,669 | $-15,805 |